Domů › Kolorektální karcinom › Virginia › Arlington
Klinické studie Kolorektální karcinom v Arlington, VA
52 studií pro Kolorektální karcinom hledá účastníky v lokalitách v Arlington a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- Virginia Cancer Specialists, Fairfax · Vzdálenost 11 mi
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1
- Inova Schar Cancer Institute, Fairfax · Vzdálenost 11 mi
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Probíhá náborFáze 1/2
- Inova Schar Cancer Institute, Fairfax · Vzdálenost 11 mi
- Virginia Cancer Specialists, PC, Fairfax · Vzdálenost 11 mi
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Probíhá náborFáze 1
- ALX Center 2, Fairfax · Vzdálenost 11 mi
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Probíhá náborFáze 2
- Virginia Cancer Specialists, Fairfax · Vzdálenost 11 mi
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Probíhá náborFáze 2
- Virginia Cancer Specialists - Fairfax /ID# 271351, Fairfax · Vzdálenost 11 mi
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Probíhá náborFáze 3
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · Vzdálenost 11 mi
- Virginia Cancer Specialists, PC, Reston · Vzdálenost 14 mi
- a dalších 1
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Probíhá náborFáze 1/2
- NEXT Oncology, Fairfax · Vzdálenost 11 mi
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Probíhá náborFáze 3
- Virginia Cancer Specialists, Arlington
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Probíhá náborFáze 3
- Virginia Cancer Specialists, Arlington
- Inova Schar Cancer Institute Dept of Fairfax Hospital, Fairfax · Vzdálenost 11 mi
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Probíhá náborFáze 2/3
- Local Institution - 0278, Fairfax · Vzdálenost 11 mi
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Probíhá náborFáze 1/2
- NEXT Oncology Virginia, Fairfax · Vzdálenost 11 mi
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Probíhá náborFáze 1/2
- Virginia Cancer Specialists, Fairfax · Vzdálenost 11 mi
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Probíhá náborFáze 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · Vzdálenost 11 mi
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Probíhá náborFáze 1
- NEXT - Virginia, Fairfax · Vzdálenost 11 mi
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Probíhá náborFáze 1/2
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- NEXT Oncology, Fairfax · Vzdálenost 11 mi
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Probíhá náborFáze 3
- Clinical Study Site, Fairfax · Vzdálenost 11 mi
The Vanguard Study: Testing a New Way to Screen for Cancer
Probíhá náborVítáni zdraví dobrovolníci
- Inova Schar Cancer Institute, Fairfax · Vzdálenost 11 mi
- Inova Fair Oaks Hospital, Fairfax · Vzdálenost 11 mi
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Probíhá náborFáze 2
- Inova Schar Cancer, Fairfax · Vzdálenost 11 mi
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Probíhá náborFáze 1
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Probíhá náborFáze 1
- NEXT Oncology, Fairfax · Vzdálenost 11 mi
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Probíhá náborFáze 1
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Clinical Trial Site, Fairfax · Vzdálenost 11 mi
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Probíhá náborFáze 1/2
- Virginia Cancer Specialists, Fairfax · Vzdálenost 11 mi
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Probíhá náborFáze 1/2
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1
- Next Virginia, Fairfax · Vzdálenost 11 mi
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Virginia Cancer Specialists, Fairfax · Vzdálenost 11 mi
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- Virginia Cancer Specialists, Fairfax · Vzdálenost 11 mi
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Probíhá náborFáze 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · Vzdálenost 11 mi
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · Vzdálenost 11 mi
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Probíhá náborFáze 1
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Probíhá náborFáze 1/2
- NEXT Oncology Virginia, Fairfax · Vzdálenost 11 mi
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Probíhá náborFáze 1
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Probíhá náborFáze 1
- NEXT Texas LLC - Virginia, Fairfax · Vzdálenost 11 mi
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Probíhá náborFáze 1
- Research Site, Fairfax · Vzdálenost 11 mi
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Probíhá náborFáze 1
- NEXT Oncology Virginia, Fairfax · Vzdálenost 11 mi
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Probíhá náborFáze 1
- NEXT Oncology Virginia, Fairfax · Vzdálenost 11 mi
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Probíhá náborFáze 1/2
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Probíhá náborFáze 1
- NEXT Oncology Virginia, Fairfax · Vzdálenost 11 mi
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Probíhá náborFáze 1/2
- Next Oncology Virginia, Fairfax · Vzdálenost 11 mi
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Probíhá náborFáze 1/2
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Probíhá náborFáze 1
- NEXT Virginia, LLC, Fairfax · Vzdálenost 11 mi
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Probíhá náborFáze 1/2
- Virginia Cancer Specialists, Fairfax · Vzdálenost 11 mi
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Probíhá náborFáze 1/2
- Virginia Cancer Specialists, Fairfax · Vzdálenost 11 mi
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Probíhá náborFáze 1/2
- Virginia Cancer Specialists, Fairfax · Vzdálenost 11 mi
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Probíhá náborFáze 1/2
- NEXT, Virginia, Fairfax · Vzdálenost 11 mi
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- NEXT Virginia, Fairfax · Vzdálenost 11 mi
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Probíhá náborFáze 1
- Virginia Cancer Specialists, Fairfax · Vzdálenost 11 mi
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Probíhá náborFáze 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · Vzdálenost 11 mi
Studie Kolorektální karcinom v jiných městech
- Houston, TX102 studií
- New York City, NY77 studií
- Nashville, TN69 studií
- Boston, MA63 studií
- Los Angeles, CA59 studií
- St. Louis, MO50 studií
- San Antonio, TX46 studií
- Philadelphia, PA44 studií
- Grand Rapids, MI40 studií
- Baldwin Park, CA38 studií
- Seattle, WA34 studií
- Tampa, FL33 studií
Další studie v Arlington
- Nemalobuněčný plicní karcinom104 studií
- Metastatický karcinom53 studií
- Rakovina (všechny typy)48 studií
- Rakovina prsu46 studií
- Rakovina vaječníků46 studií
- Rakovina plic41 studií
- Rakovina endometria39 studií
- Rakovina slinivky břišní33 studií
- Squamózní buněčný karcinom hlavy a krku26 studií
- Malobuněčný karcinom plic23 studií
- Trojně negativní rakovina prsu20 studií
- Rakovina žaludku20 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.